topper's finally got some new material, page-32

re: undervalued profitable sirtex I have found over the years that buying FDA approved biotechs like Sirtex takes some of the risk out and puts more reward there. Also when revenue growth starts expanding alot and they are turning corner into profitability and expanding usage helps too for the product. Contracts with large pharma parteners adds to the run as Sirtex has been doing trials with Sanofi and Pfizer. Managment owns alot of shares so they are out for themselves too in addition to shareholders.Knowing the field helps which I am pretty knowledgeable about. In this age where Genenentech sells at 20x sales and 100x earnings with 30 % growth makes a co like Sirtex that is 4x next years sales and 10x next years earnings estimates with alot of investment not have to be spent again and growing now over 100 % makes it look pretty decent. This is my way evaluating it, but do your own research of course.